Epidemic (human immunodeficiency virus-related) Kaposi's sarcoma in West African women
โ Scribed by Edith N. Nnoruka
- Book ID
- 104464004
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 136 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0011-9059
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Background Most patients infected with human immunodeficiency virus (HIV) experience skin disease at some stage of their illness, either as a presenting feature or as a later manifestation. Different dermatoses may coexist during the course of the infection, and the unusual nature of the skin lesions can make an accurate diagnosis difficult. Kaposi's sarcoma is one of the acquired immunodeficiency syndrome (AIDS)โdefining skin diseases and may coexist with other lesions in AIDS patients. Kaposi's sarcoma is caused by human herpesvirus 8 (HHV8), which is mainly transmitted through male homosexual behavior, and is less common in women than in men.
Methods The clinical, histopathologic, and therapeutic aspects of AIDSโrelated Kaposi's sarcoma in three women (age, 18โ34ย years) who presented to the dermatology clinic of the University of Nigeria Teaching Hospital, Enugu, Nigeria, were studied over 18ย months, beginning in August and September 1998.
Results At presentation, the condition of the three patients was generally poor, with severe anemia and extensive darkโbrown papules, plaques, and nodules. Mucosal involvement was extensive. Generalized lymphadenopathy was found in two patients, one of whom had extensive coexisting dermatophytosis. All three women were in stage III/IV of the disease at the time of initial presentation. Death occurred within days in one and within 7โ8ย months in two.
Conclusions Because these female patients with epidemic Kaposi's sarcoma lived in an almost entirely heterosexual population, the mode of contamination with HHV8 was obscure. The course of the disease was pervasive, aggressive, and devastating.
๐ SIMILAR VOLUMES
## Background: Kaposi's sarcoma-associated herpesvirus (kshv) dna sequences have been identified in approximately 95% of kaposi's sarcoma (ks) lesions and primary effusion lymphomas (pels), suggesting a pathogenetic role for this virus in these lesions. however, kshv has also been identified in a v